Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type 1 selected

Type

Guidance programme

Showing 1451 to 1475 of 1904

TitleReference numberPublishedLast updated
Deep dermal injection of non-absorbable gel polymer for HIV-related lipoatrophyIPG439
Ipilimumab for previously treated advanced (unresectable or metastatic) melanomaTA268
Decitabine for the treatment of acute myeloid leukaemia (terminated appraisal)TA270
Dronedarone for the treatment of non-permanent atrial fibrillationTA197
Mannitol dry powder for inhalation for treating cystic fibrosisTA266
Ivabradine for treating chronic heart failureTA267
Physical activity: walking and cyclingPH41
Laparoscopic gastric plication for the treatment of severe obesityIPG432
Percutaneous laser atherectomy as an adjunct to balloon angioplasty (with or without stenting) for peripheral arterial diseaseIPG433
Radiofrequency cold ablation for respiratory papillomatosisIPG434
Depth of anaesthesia monitors – Bispectral Index (BIS), E-Entropy and Narcotrend-Compact MDG6
Denosumab for the prevention of skeletal-related events in adults with bone metastases from solid tumoursTA265
Social and emotional wellbeing: early yearsPH40
Alteplase for treating acute ischaemic strokeTA264
Neutropenic sepsis: prevention and management in people with cancerCG151
SonoVue (sulphur hexafluoride microbubbles) – contrast agent for contrast-enhanced ultrasound imaging of the liverDG5
Bevacizumab in combination with capecitabine for the first-line treatment of metastatic breast cancerTA263
Mega Soft Patient Return Electrode for use during monopolar electrosurgeryMTG11
Rivaroxaban for the treatment of deep vein thrombosis and prevention of recurrent deep vein thrombosis and pulmonary embolismTA261
Endovascular stent insertion for intracranial atherosclerotic diseaseIPG429
Partial replacement of the meniscus of the knee using a biodegradable scaffoldIPG430
Lapatinib or trastuzumab in combination with an aromatase inhibitor for the first-line treatment of metastatic hormone-receptor-positive breast cancer that overexpresses HER2TA257
Erlotinib for the first-line treatment of locally advanced or metastatic EGFR-TK mutation-positive non-small-cell lung cancerTA258
Botulinum toxin type A for the prevention of headaches in adults with chronic migraineTA260
Sickle cell disease: managing acute painful episodes in hospitalCG143

Results per page

  1. 10
  2. 25
  3. 50
  4. All